Medicine
Prialt 500 mcg/5 mL injection
Prialt 500 mcg/5 mL injection is a prescription medicine containing Ziconotide for intrathecal use, marketed by Esteve Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store PRIALT at 2°C to 8°C (36°F to 46°F). Do NOT freeze PRIALT. PRIALT, once…
Key facts
- Active ingredient (INN)
- Ziconotide
- Brand
- Prialt
- Strength
- 500 mcg/5 mL
- Dosage form
- Injection
- Route
- Intrathecal
- Packs
- 1 vial of 5 mL
- Marketing authorisation holder
- Esteve Pharmaceuticals
- Manufacturers
- Esteve PharmaceuticalsTerSera Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store PRIALT at 2°C to 8°C (36°F to 46°F). Do NOT freeze PRIALT. PRIALT, once diluted aseptically with saline, may be stored at 2°C to 8°C for 24 hours. Protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N02BG08 Ziconotide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 October 2018
- Identifiers
- RxCUI 486133, 583453, 1738353 +3DailyMed set ID b025d8ed-937d-4597-9ad1-0b2f6e0ee5b1, 57376a5b-4530-9018-e063-6394a90a9afeNDC 70720-722, 68118-722Application NDA021060
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, glass in 1 carton / 5 mL in 1 vial, glass | 68118-722-10 | Esteve Pharmaceuticals | 15 August 2019 |
| 1 vial, glass in 1 carton / 5 mL in 1 vial, glass | 70720-722-10 | TerSera Therapeutics | 15 August 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ziconotide
Clinical summary
Ziconotide is a N-type calcium channel antagonist indicated for the management of severe chronic pain in adult patients for whom intrathecal therapy is warranted,, among other approved uses. MedsAcross supplies Ziconotide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ZiconotideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- PRIALT prescribing information (Esteve Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Prialt: European public assessment report (EPAR) · European Medicines Agency
Need Prialt 500 mcg/5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.